nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—UGT1A1—Abacavir—acquired immunodeficiency syndrome	0.0509	0.0665	CbGbCtD
Lovastatin—UGT2B7—Zidovudine—acquired immunodeficiency syndrome	0.0276	0.036	CbGbCtD
Lovastatin—SLCO1A2—Indinavir—acquired immunodeficiency syndrome	0.0208	0.0272	CbGbCtD
Lovastatin—SLCO1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0202	0.0264	CbGbCtD
Lovastatin—SLCO1B1—Indinavir—acquired immunodeficiency syndrome	0.0196	0.0256	CbGbCtD
Lovastatin—SLCO1B1—Nelfinavir—acquired immunodeficiency syndrome	0.019	0.0249	CbGbCtD
Lovastatin—SLCO1A2—Saquinavir—acquired immunodeficiency syndrome	0.0182	0.0238	CbGbCtD
Lovastatin—SLCO1A2—Ritonavir—acquired immunodeficiency syndrome	0.0182	0.0238	CbGbCtD
Lovastatin—ABCC2—Indinavir—acquired immunodeficiency syndrome	0.0172	0.0225	CbGbCtD
Lovastatin—SLCO1B1—Saquinavir—acquired immunodeficiency syndrome	0.0172	0.0225	CbGbCtD
Lovastatin—SLCO1B1—Ritonavir—acquired immunodeficiency syndrome	0.0172	0.0225	CbGbCtD
Lovastatin—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.0151	0.0198	CbGbCtD
Lovastatin—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.0151	0.0198	CbGbCtD
Lovastatin—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0133	0.0174	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0133	0.0174	CbGbCtD
Lovastatin—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0115	0.015	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0115	0.015	CbGbCtD
Lovastatin—ABCC2—Lamivudine—acquired immunodeficiency syndrome	0.0112	0.0147	CbGbCtD
Lovastatin—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.0112	0.0146	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.0112	0.0146	CbGbCtD
Lovastatin—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.011	0.0144	CbGbCtD
Lovastatin—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.0101	0.0132	CbGbCtD
Lovastatin—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.0101	0.0132	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.0101	0.0132	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.0101	0.0132	CbGbCtD
Lovastatin—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.00999	0.0131	CbGbCtD
Lovastatin—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.00999	0.0131	CbGbCtD
Lovastatin—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0096	0.0126	CbGbCtD
Lovastatin—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0096	0.0126	CbGbCtD
Lovastatin—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.00947	0.0124	CbGbCtD
Lovastatin—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.00891	0.0117	CbGbCtD
Lovastatin—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.00862	0.0113	CbGbCtD
Lovastatin—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.00837	0.0109	CbGbCtD
Lovastatin—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.00806	0.0105	CbGbCtD
Lovastatin—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.00806	0.0105	CbGbCtD
Lovastatin—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00788	0.0103	CbGbCtD
Lovastatin—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.00757	0.0099	CbGbCtD
Lovastatin—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.00757	0.0099	CbGbCtD
Lovastatin—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00741	0.00969	CbGbCtD
Lovastatin—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00741	0.00969	CbGbCtD
Lovastatin—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.00728	0.00952	CbGbCtD
Lovastatin—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.00728	0.00952	CbGbCtD
Lovastatin—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0072	0.00942	CbGbCtD
Lovastatin—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00719	0.0094	CbGbCtD
Lovastatin—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.00698	0.00913	CbGbCtD
Lovastatin—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.00695	0.0091	CbGbCtD
Lovastatin—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.00677	0.00886	CbGbCtD
Lovastatin—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.00677	0.00886	CbGbCtD
Lovastatin—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.00675	0.00883	CbGbCtD
Lovastatin—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0067	0.00876	CbGbCtD
Lovastatin—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0067	0.00876	CbGbCtD
Lovastatin—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0065	0.0085	CbGbCtD
Lovastatin—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00612	0.00801	CbGbCtD
Lovastatin—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00612	0.00801	CbGbCtD
Lovastatin—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0061	0.00799	CbGbCtD
Lovastatin—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0061	0.00799	CbGbCtD
Lovastatin—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00585	0.00766	CbGbCtD
Lovastatin—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00578	0.00756	CbGbCtD
Lovastatin—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00561	0.00734	CbGbCtD
Lovastatin—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00561	0.00734	CbGbCtD
Lovastatin—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00545	0.00713	CbGbCtD
Lovastatin—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00529	0.00692	CbGbCtD
Lovastatin—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00513	0.00671	CbGbCtD
Lovastatin—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00508	0.00664	CbGbCtD
Lovastatin—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00508	0.00664	CbGbCtD
Lovastatin—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00493	0.00644	CbGbCtD
Lovastatin—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00493	0.00644	CbGbCtD
Lovastatin—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00487	0.00637	CbGbCtD
Lovastatin—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00472	0.00618	CbGbCtD
Lovastatin—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00464	0.00607	CbGbCtD
Lovastatin—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00464	0.00607	CbGbCtD
Lovastatin—ITGAL—endothelium—acquired immunodeficiency syndrome	0.00458	0.0797	CbGeAlD
Lovastatin—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00458	0.00599	CbGbCtD
Lovastatin—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00431	0.00563	CbGbCtD
Lovastatin—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00431	0.00563	CbGbCtD
Lovastatin—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00389	0.0051	CbGbCtD
Lovastatin—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00389	0.0051	CbGbCtD
Lovastatin—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00365	0.00478	CbGbCtD
Lovastatin—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00336	0.0044	CbGbCtD
Lovastatin—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00326	0.00427	CbGbCtD
Lovastatin—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00295	0.00386	CbGbCtD
Lovastatin—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00295	0.00386	CbGbCtD
Lovastatin—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00283	0.0037	CbGbCtD
Lovastatin—UGT1A1—blood plasma—acquired immunodeficiency syndrome	0.00169	0.0294	CbGeAlD
Lovastatin—ITGAL—lymphoid tissue—acquired immunodeficiency syndrome	0.00158	0.0276	CbGeAlD
Lovastatin—ITGAL—digestive system—acquired immunodeficiency syndrome	0.00156	0.0272	CbGeAlD
Lovastatin—ITGAL—blood—acquired immunodeficiency syndrome	0.00149	0.0259	CbGeAlD
Lovastatin—HMGCR—blood plasma—acquired immunodeficiency syndrome	0.00147	0.0255	CbGeAlD
Lovastatin—ITGAL—bone marrow—acquired immunodeficiency syndrome	0.00144	0.0251	CbGeAlD
Lovastatin—ITGAL—spinal cord—acquired immunodeficiency syndrome	0.00144	0.025	CbGeAlD
Lovastatin—PON3—bone marrow—acquired immunodeficiency syndrome	0.00141	0.0246	CbGeAlD
Lovastatin—SLCO1B1—blood plasma—acquired immunodeficiency syndrome	0.00141	0.0245	CbGeAlD
Lovastatin—ITGAL—vagina—acquired immunodeficiency syndrome	0.00138	0.024	CbGeAlD
Lovastatin—PON3—vagina—acquired immunodeficiency syndrome	0.00135	0.0236	CbGeAlD
Lovastatin—UGT1A3—digestive system—acquired immunodeficiency syndrome	0.00133	0.0231	CbGeAlD
Lovastatin—ITGAL—lung—acquired immunodeficiency syndrome	0.00131	0.0227	CbGeAlD
Lovastatin—PON3—lung—acquired immunodeficiency syndrome	0.00128	0.0223	CbGeAlD
Lovastatin—ITGAL—brain—acquired immunodeficiency syndrome	0.000925	0.0161	CbGeAlD
Lovastatin—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000916	0.0159	CbGeAlD
Lovastatin—PON3—brain—acquired immunodeficiency syndrome	0.000907	0.0158	CbGeAlD
Lovastatin—ITGAL—lymph node—acquired immunodeficiency syndrome	0.000894	0.0155	CbGeAlD
Lovastatin—HDAC2—retina—acquired immunodeficiency syndrome	0.00089	0.0155	CbGeAlD
Lovastatin—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000799	0.0139	CbGeAlD
Lovastatin—HDAC2—skin of body—acquired immunodeficiency syndrome	0.000782	0.0136	CbGeAlD
Lovastatin—UGT2B7—digestive system—acquired immunodeficiency syndrome	0.000764	0.0133	CbGeAlD
Lovastatin—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000721	0.0125	CbGeAlD
Lovastatin—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00071	0.0124	CbGeAlD
Lovastatin—HMGCR—skin of body—acquired immunodeficiency syndrome	0.000705	0.0123	CbGeAlD
Lovastatin—UGT1A1—digestive system—acquired immunodeficiency syndrome	0.00065	0.0113	CbGeAlD
Lovastatin—HDAC2—lymphoid tissue—acquired immunodeficiency syndrome	0.000633	0.011	CbGeAlD
Lovastatin—HDAC2—digestive system—acquired immunodeficiency syndrome	0.000625	0.0109	CbGeAlD
Lovastatin—UGT1A1—blood—acquired immunodeficiency syndrome	0.000619	0.0108	CbGeAlD
Lovastatin—HDAC2—blood—acquired immunodeficiency syndrome	0.000596	0.0104	CbGeAlD
Lovastatin—HDAC2—bone marrow—acquired immunodeficiency syndrome	0.000576	0.01	CbGeAlD
Lovastatin—HMGCR—lymphoid tissue—acquired immunodeficiency syndrome	0.000571	0.00994	CbGeAlD
Lovastatin—HMGCR—digestive system—acquired immunodeficiency syndrome	0.000564	0.00982	CbGeAlD
Lovastatin—HDAC2—vagina—acquired immunodeficiency syndrome	0.000552	0.00961	CbGeAlD
Lovastatin—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000541	0.00942	CbGeAlD
Lovastatin—SLCO1B1—digestive system—acquired immunodeficiency syndrome	0.000541	0.0094	CbGeAlD
Lovastatin—HMGCR—blood—acquired immunodeficiency syndrome	0.000538	0.00935	CbGeAlD
Lovastatin—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000533	0.00927	CbGeAlD
Lovastatin—HDAC2—lung—acquired immunodeficiency syndrome	0.000522	0.00908	CbGeAlD
Lovastatin—HMGCR—bone marrow—acquired immunodeficiency syndrome	0.00052	0.00905	CbGeAlD
Lovastatin—HMGCR—spinal cord—acquired immunodeficiency syndrome	0.000518	0.00901	CbGeAlD
Lovastatin—SLCO1B1—blood—acquired immunodeficiency syndrome	0.000515	0.00896	CbGeAlD
Lovastatin—HMGCR—vagina—acquired immunodeficiency syndrome	0.000498	0.00867	CbGeAlD
Lovastatin—HDAC2—nervous system—acquired immunodeficiency syndrome	0.000484	0.00841	CbGeAlD
Lovastatin—HMGCR—lung—acquired immunodeficiency syndrome	0.000471	0.0082	CbGeAlD
Lovastatin—HDAC2—central nervous system—acquired immunodeficiency syndrome	0.000466	0.0081	CbGeAlD
Lovastatin—SLCO1A2—digestive system—acquired immunodeficiency syndrome	0.00044	0.00765	CbGeAlD
Lovastatin—HMGCR—nervous system—acquired immunodeficiency syndrome	0.000436	0.00759	CbGeAlD
Lovastatin—HMGCR—central nervous system—acquired immunodeficiency syndrome	0.00042	0.00731	CbGeAlD
Lovastatin—ABCC2—digestive system—acquired immunodeficiency syndrome	0.00041	0.00713	CbGeAlD
Lovastatin—SLCO1A2—spinal cord—acquired immunodeficiency syndrome	0.000404	0.00702	CbGeAlD
Lovastatin—ABCC2—blood—acquired immunodeficiency syndrome	0.00039	0.00679	CbGeAlD
Lovastatin—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000383	0.00667	CbGeAlD
Lovastatin—HDAC2—brain—acquired immunodeficiency syndrome	0.00037	0.00643	CbGeAlD
Lovastatin—SLCO1A2—lung—acquired immunodeficiency syndrome	0.000367	0.00639	CbGeAlD
Lovastatin—HDAC2—lymph node—acquired immunodeficiency syndrome	0.000357	0.00621	CbGeAlD
Lovastatin—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000352	0.00613	CbGeAlD
Lovastatin—SLCO1A2—nervous system—acquired immunodeficiency syndrome	0.00034	0.00592	CbGeAlD
Lovastatin—CYP2C19—blood—acquired immunodeficiency syndrome	0.000335	0.00584	CbGeAlD
Lovastatin—HMGCR—brain—acquired immunodeficiency syndrome	0.000334	0.0058	CbGeAlD
Lovastatin—SLCO1A2—central nervous system—acquired immunodeficiency syndrome	0.000328	0.0057	CbGeAlD
Lovastatin—HMGCR—lymph node—acquired immunodeficiency syndrome	0.000322	0.00561	CbGeAlD
Lovastatin—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000311	0.00541	CbGeAlD
Lovastatin—CYP2C8—blood—acquired immunodeficiency syndrome	0.000293	0.00509	CbGeAlD
Lovastatin—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000277	0.00483	CbGeAlD
Lovastatin—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000273	0.00475	CbGeAlD
Lovastatin—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000271	0.00472	CbGeAlD
Lovastatin—CYP3A5—blood—acquired immunodeficiency syndrome	0.000264	0.0046	CbGeAlD
Lovastatin—CYP2C9—blood—acquired immunodeficiency syndrome	0.00026	0.00452	CbGeAlD
Lovastatin—SLCO1A2—brain—acquired immunodeficiency syndrome	0.00026	0.00452	CbGeAlD
Lovastatin—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000245	0.00426	CbGeAlD
Lovastatin—ABCC2—lymph node—acquired immunodeficiency syndrome	0.000234	0.00407	CbGeAlD
Lovastatin—CYP3A5—lung—acquired immunodeficiency syndrome	0.000232	0.00403	CbGeAlD
Lovastatin—ABCB1—retina—acquired immunodeficiency syndrome	0.00021	0.00365	CbGeAlD
Lovastatin—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000208	0.00362	CbGeAlD
Lovastatin—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000205	0.00356	CbGeAlD
Lovastatin—CYP3A4—blood—acquired immunodeficiency syndrome	0.000198	0.00345	CbGeAlD
Lovastatin—CYP2D6—blood—acquired immunodeficiency syndrome	0.000195	0.0034	CbGeAlD
Lovastatin—CYP2C8—brain—acquired immunodeficiency syndrome	0.000182	0.00316	CbGeAlD
Lovastatin—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000161	0.0028	CbGeAlD
Lovastatin—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000158	0.00276	CbGeAlD
Lovastatin—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000155	0.0027	CbGeAlD
Lovastatin—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000153	0.000865	CcSEcCtD
Lovastatin—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000153	0.000864	CcSEcCtD
Lovastatin—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000153	0.00265	CbGeAlD
Lovastatin—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.000862	CcSEcCtD
Lovastatin—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.00086	CcSEcCtD
Lovastatin—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000152	0.00086	CcSEcCtD
Lovastatin—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000151	0.000857	CcSEcCtD
Lovastatin—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000151	0.000857	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000151	0.000857	CcSEcCtD
Lovastatin—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000151	0.000856	CcSEcCtD
Lovastatin—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000151	0.000852	CcSEcCtD
Lovastatin—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000151	0.000852	CcSEcCtD
Lovastatin—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.00015	0.000851	CcSEcCtD
Lovastatin—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.00085	CcSEcCtD
Lovastatin—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.00015	0.000847	CcSEcCtD
Lovastatin—Rash—Didanosine—acquired immunodeficiency syndrome	0.000149	0.000845	CcSEcCtD
Lovastatin—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000149	0.000845	CcSEcCtD
Lovastatin—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000149	0.0026	CbGeAlD
Lovastatin—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000149	0.000844	CcSEcCtD
Lovastatin—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000149	0.000844	CcSEcCtD
Lovastatin—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000149	0.000844	CcSEcCtD
Lovastatin—Headache—Didanosine—acquired immunodeficiency syndrome	0.000148	0.000839	CcSEcCtD
Lovastatin—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000148	0.000838	CcSEcCtD
Lovastatin—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000148	0.000837	CcSEcCtD
Lovastatin—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000148	0.000836	CcSEcCtD
Lovastatin—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000147	0.000835	CcSEcCtD
Lovastatin—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000147	0.00256	CbGeAlD
Lovastatin—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000147	0.000833	CcSEcCtD
Lovastatin—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000833	CcSEcCtD
Lovastatin—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000147	0.000832	CcSEcCtD
Lovastatin—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.00083	CcSEcCtD
Lovastatin—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.000829	CcSEcCtD
Lovastatin—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000146	0.000828	CcSEcCtD
Lovastatin—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000146	0.000827	CcSEcCtD
Lovastatin—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000146	0.000826	CcSEcCtD
Lovastatin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000146	0.000824	CcSEcCtD
Lovastatin—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000145	0.000823	CcSEcCtD
Lovastatin—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000145	0.000822	CcSEcCtD
Lovastatin—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000821	CcSEcCtD
Lovastatin—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.00082	CcSEcCtD
Lovastatin—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.00082	CcSEcCtD
Lovastatin—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.00082	CcSEcCtD
Lovastatin—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000144	0.000817	CcSEcCtD
Lovastatin—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000817	CcSEcCtD
Lovastatin—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000143	0.000811	CcSEcCtD
Lovastatin—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000143	0.000811	CcSEcCtD
Lovastatin—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000143	0.00081	CcSEcCtD
Lovastatin—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.00081	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.000809	CcSEcCtD
Lovastatin—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000808	CcSEcCtD
Lovastatin—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000142	0.000804	CcSEcCtD
Lovastatin—Pain—Indinavir—acquired immunodeficiency syndrome	0.000142	0.000804	CcSEcCtD
Lovastatin—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000142	0.000804	CcSEcCtD
Lovastatin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000142	0.000803	CcSEcCtD
Lovastatin—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000802	CcSEcCtD
Lovastatin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000141	0.000799	CcSEcCtD
Lovastatin—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000141	0.000799	CcSEcCtD
Lovastatin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000141	0.000798	CcSEcCtD
Lovastatin—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000141	0.000798	CcSEcCtD
Lovastatin—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000798	CcSEcCtD
Lovastatin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000141	0.000796	CcSEcCtD
Lovastatin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000141	0.000796	CcSEcCtD
Lovastatin—ABCB1—blood—acquired immunodeficiency syndrome	0.00014	0.00244	CbGeAlD
Lovastatin—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000795	CcSEcCtD
Lovastatin—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000793	CcSEcCtD
Lovastatin—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00014	0.000792	CcSEcCtD
Lovastatin—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000792	CcSEcCtD
Lovastatin—ITGAL—Beta2 integrin cell surface interactions—CD40LG—acquired immunodeficiency syndrome	0.00014	0.0896	CbGpPWpGaD
Lovastatin—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000789	CcSEcCtD
Lovastatin—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000789	CcSEcCtD
Lovastatin—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000789	CcSEcCtD
Lovastatin—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000787	CcSEcCtD
Lovastatin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000139	0.000784	CcSEcCtD
Lovastatin—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000138	0.000782	CcSEcCtD
Lovastatin—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.00078	CcSEcCtD
Lovastatin—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000137	0.000775	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000775	CcSEcCtD
Lovastatin—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000136	0.000772	CcSEcCtD
Lovastatin—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000772	CcSEcCtD
Lovastatin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000136	0.000772	CcSEcCtD
Lovastatin—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.00077	CcSEcCtD
Lovastatin—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000136	0.000769	CcSEcCtD
Lovastatin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000136	0.000769	CcSEcCtD
Lovastatin—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000136	0.00236	CbGeAlD
Lovastatin—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000136	0.000769	CcSEcCtD
Lovastatin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000135	0.000766	CcSEcCtD
Lovastatin—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000135	0.000766	CcSEcCtD
Lovastatin—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000135	0.00235	CbGeAlD
Lovastatin—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000135	0.000763	CcSEcCtD
Lovastatin—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000763	CcSEcCtD
Lovastatin—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000134	0.00076	CcSEcCtD
Lovastatin—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000134	0.00076	CcSEcCtD
Lovastatin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000134	0.00076	CcSEcCtD
Lovastatin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000134	0.000759	CcSEcCtD
Lovastatin—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000134	0.000758	CcSEcCtD
Lovastatin—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000134	0.000758	CcSEcCtD
Lovastatin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000133	0.000755	CcSEcCtD
Lovastatin—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000753	CcSEcCtD
Lovastatin—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000753	CcSEcCtD
Lovastatin—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000753	CcSEcCtD
Lovastatin—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000133	0.000752	CcSEcCtD
Lovastatin—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.00075	CcSEcCtD
Lovastatin—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.000749	CcSEcCtD
Lovastatin—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000132	0.000748	CcSEcCtD
Lovastatin—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000132	0.000747	CcSEcCtD
Lovastatin—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000744	CcSEcCtD
Lovastatin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000131	0.000743	CcSEcCtD
Lovastatin—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000131	0.000743	CcSEcCtD
Lovastatin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000131	0.000742	CcSEcCtD
Lovastatin—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.000741	CcSEcCtD
Lovastatin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000131	0.00074	CcSEcCtD
Lovastatin—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000131	0.000739	CcSEcCtD
Lovastatin—ABCB1—vagina—acquired immunodeficiency syndrome	0.00013	0.00226	CbGeAlD
Lovastatin—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000736	CcSEcCtD
Lovastatin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00013	0.000736	CcSEcCtD
Lovastatin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00013	0.000735	CcSEcCtD
Lovastatin—Rash—Stavudine—acquired immunodeficiency syndrome	0.00013	0.000734	CcSEcCtD
Lovastatin—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.000733	CcSEcCtD
Lovastatin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000129	0.000733	CcSEcCtD
Lovastatin—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000129	0.000732	CcSEcCtD
Lovastatin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000129	0.000731	CcSEcCtD
Lovastatin—Headache—Stavudine—acquired immunodeficiency syndrome	0.000129	0.000729	CcSEcCtD
Lovastatin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000129	0.000729	CcSEcCtD
Lovastatin—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000728	CcSEcCtD
Lovastatin—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000128	0.000727	CcSEcCtD
Lovastatin—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000128	0.000727	CcSEcCtD
Lovastatin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.000727	CcSEcCtD
Lovastatin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000128	0.000725	CcSEcCtD
Lovastatin—Rash—Abacavir—acquired immunodeficiency syndrome	0.000128	0.000723	CcSEcCtD
Lovastatin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000128	0.000722	CcSEcCtD
Lovastatin—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000722	CcSEcCtD
Lovastatin—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000721	CcSEcCtD
Lovastatin—Headache—Abacavir—acquired immunodeficiency syndrome	0.000127	0.000718	CcSEcCtD
Lovastatin—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.000717	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000716	CcSEcCtD
Lovastatin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000126	0.000716	CcSEcCtD
Lovastatin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000126	0.000715	CcSEcCtD
Lovastatin—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000711	CcSEcCtD
Lovastatin—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.000707	CcSEcCtD
Lovastatin—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.000706	CcSEcCtD
Lovastatin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000125	0.000706	CcSEcCtD
Lovastatin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000124	0.000702	CcSEcCtD
Lovastatin—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000124	0.000702	CcSEcCtD
Lovastatin—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000124	0.000701	CcSEcCtD
Lovastatin—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000124	0.000701	CcSEcCtD
Lovastatin—ABCB1—lung—acquired immunodeficiency syndrome	0.000123	0.00214	CbGeAlD
Lovastatin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.000695	CcSEcCtD
Lovastatin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000122	0.000693	CcSEcCtD
Lovastatin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000122	0.000693	CcSEcCtD
Lovastatin—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000692	CcSEcCtD
Lovastatin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000122	0.000692	CcSEcCtD
Lovastatin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000122	0.000691	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000689	CcSEcCtD
Lovastatin—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000688	CcSEcCtD
Lovastatin—CYP2D6—brain—acquired immunodeficiency syndrome	0.000121	0.00211	CbGeAlD
Lovastatin—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000684	CcSEcCtD
Lovastatin—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000683	CcSEcCtD
Lovastatin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00012	0.000681	CcSEcCtD
Lovastatin—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000679	CcSEcCtD
Lovastatin—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000678	CcSEcCtD
Lovastatin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000119	0.000675	CcSEcCtD
Lovastatin—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000119	0.000675	CcSEcCtD
Lovastatin—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000675	CcSEcCtD
Lovastatin—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000672	CcSEcCtD
Lovastatin—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000672	CcSEcCtD
Lovastatin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000119	0.000672	CcSEcCtD
Lovastatin—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000119	0.000672	CcSEcCtD
Lovastatin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000118	0.000669	CcSEcCtD
Lovastatin—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000666	CcSEcCtD
Lovastatin—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000118	0.000665	CcSEcCtD
Lovastatin—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000658	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000658	CcSEcCtD
Lovastatin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000116	0.000655	CcSEcCtD
Lovastatin—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000653	CcSEcCtD
Lovastatin—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000652	CcSEcCtD
Lovastatin—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000648	CcSEcCtD
Lovastatin—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000648	CcSEcCtD
Lovastatin—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000647	CcSEcCtD
Lovastatin—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000647	CcSEcCtD
Lovastatin—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000114	0.00198	CbGeAlD
Lovastatin—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000644	CcSEcCtD
Lovastatin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000114	0.000643	CcSEcCtD
Lovastatin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000114	0.000643	CcSEcCtD
Lovastatin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000643	CcSEcCtD
Lovastatin—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000113	0.000638	CcSEcCtD
Lovastatin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000637	CcSEcCtD
Lovastatin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000113	0.000637	CcSEcCtD
Lovastatin—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000635	CcSEcCtD
Lovastatin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000112	0.000633	CcSEcCtD
Lovastatin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.000629	CcSEcCtD
Lovastatin—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000627	CcSEcCtD
Lovastatin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000111	0.000626	CcSEcCtD
Lovastatin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000625	CcSEcCtD
Lovastatin—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000624	CcSEcCtD
Lovastatin—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000622	CcSEcCtD
Lovastatin—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00011	0.000622	CcSEcCtD
Lovastatin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000621	CcSEcCtD
Lovastatin—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000621	CcSEcCtD
Lovastatin—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.00011	0.00191	CbGeAlD
Lovastatin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000619	CcSEcCtD
Lovastatin—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000617	CcSEcCtD
Lovastatin—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000617	CcSEcCtD
Lovastatin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.00061	CcSEcCtD
Lovastatin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.000608	CcSEcCtD
Lovastatin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.000601	CcSEcCtD
Lovastatin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000601	CcSEcCtD
Lovastatin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000106	0.000601	CcSEcCtD
Lovastatin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000598	CcSEcCtD
Lovastatin—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000598	CcSEcCtD
Lovastatin—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000106	0.000598	CcSEcCtD
Lovastatin—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000595	CcSEcCtD
Lovastatin—Rash—Indinavir—acquired immunodeficiency syndrome	0.000105	0.000593	CcSEcCtD
Lovastatin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000105	0.000592	CcSEcCtD
Lovastatin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.00059	CcSEcCtD
Lovastatin—Headache—Indinavir—acquired immunodeficiency syndrome	0.000104	0.000589	CcSEcCtD
Lovastatin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000588	CcSEcCtD
Lovastatin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.000582	CcSEcCtD
Lovastatin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000579	CcSEcCtD
Lovastatin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000573	CcSEcCtD
Lovastatin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000571	CcSEcCtD
Lovastatin—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000571	CcSEcCtD
Lovastatin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	9.98e-05	0.000565	CcSEcCtD
Lovastatin—HDAC2—Initiation of transcription and translation elongation at the HIV-1 LTR—CCNT1—acquired immunodeficiency syndrome	9.97e-05	0.0639	CbGpPWpGaD
Lovastatin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	9.96e-05	0.000564	CcSEcCtD
Lovastatin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	9.93e-05	0.000562	CcSEcCtD
Lovastatin—Rash—Efavirenz—acquired immunodeficiency syndrome	9.9e-05	0.00056	CcSEcCtD
Lovastatin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	9.89e-05	0.00056	CcSEcCtD
Lovastatin—Nausea—Indinavir—acquired immunodeficiency syndrome	9.87e-05	0.000559	CcSEcCtD
Lovastatin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	9.85e-05	0.000557	CcSEcCtD
Lovastatin—Headache—Efavirenz—acquired immunodeficiency syndrome	9.83e-05	0.000557	CcSEcCtD
Lovastatin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	9.83e-05	0.000556	CcSEcCtD
Lovastatin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	9.59e-05	0.000543	CcSEcCtD
Lovastatin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	9.55e-05	0.000541	CcSEcCtD
Lovastatin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	9.5e-05	0.000538	CcSEcCtD
Lovastatin—Rash—Delavirdine—acquired immunodeficiency syndrome	9.47e-05	0.000536	CcSEcCtD
Lovastatin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	9.46e-05	0.000536	CcSEcCtD
Lovastatin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	9.46e-05	0.000535	CcSEcCtD
Lovastatin—Headache—Delavirdine—acquired immunodeficiency syndrome	9.41e-05	0.000533	CcSEcCtD
Lovastatin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	9.39e-05	0.000532	CcSEcCtD
Lovastatin—Nausea—Efavirenz—acquired immunodeficiency syndrome	9.32e-05	0.000528	CcSEcCtD
Lovastatin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	9.18e-05	0.00052	CcSEcCtD
Lovastatin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	9.15e-05	0.000518	CcSEcCtD
Lovastatin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	9.15e-05	0.000518	CcSEcCtD
Lovastatin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	9.02e-05	0.000511	CcSEcCtD
Lovastatin—Nausea—Delavirdine—acquired immunodeficiency syndrome	8.92e-05	0.000505	CcSEcCtD
Lovastatin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	8.84e-05	0.0005	CcSEcCtD
Lovastatin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	8.83e-05	0.0005	CcSEcCtD
Lovastatin—Rash—Ritonavir—acquired immunodeficiency syndrome	8.76e-05	0.000496	CcSEcCtD
Lovastatin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	8.75e-05	0.000495	CcSEcCtD
Lovastatin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	8.72e-05	0.000494	CcSEcCtD
Lovastatin—ABCB1—brain—acquired immunodeficiency syndrome	8.71e-05	0.00152	CbGeAlD
Lovastatin—Headache—Ritonavir—acquired immunodeficiency syndrome	8.7e-05	0.000492	CcSEcCtD
Lovastatin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	8.5e-05	0.000481	CcSEcCtD
Lovastatin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	8.43e-05	0.000477	CcSEcCtD
Lovastatin—Rash—Saquinavir—acquired immunodeficiency syndrome	8.43e-05	0.000477	CcSEcCtD
Lovastatin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	8.42e-05	0.000477	CcSEcCtD
Lovastatin—ABCB1—lymph node—acquired immunodeficiency syndrome	8.42e-05	0.00146	CbGeAlD
Lovastatin—Headache—Saquinavir—acquired immunodeficiency syndrome	8.37e-05	0.000474	CcSEcCtD
Lovastatin—Nausea—Ritonavir—acquired immunodeficiency syndrome	8.25e-05	0.000467	CcSEcCtD
Lovastatin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	8.11e-05	0.000459	CcSEcCtD
Lovastatin—Rash—Lamivudine—acquired immunodeficiency syndrome	8.04e-05	0.000455	CcSEcCtD
Lovastatin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	8.03e-05	0.000455	CcSEcCtD
Lovastatin—Headache—Lamivudine—acquired immunodeficiency syndrome	7.99e-05	0.000452	CcSEcCtD
Lovastatin—Nausea—Saquinavir—acquired immunodeficiency syndrome	7.94e-05	0.000449	CcSEcCtD
Lovastatin—Nausea—Lamivudine—acquired immunodeficiency syndrome	7.57e-05	0.000429	CcSEcCtD
Lovastatin—ITGAL—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—CD40LG—acquired immunodeficiency syndrome	6.9e-05	0.0443	CbGpPWpGaD
Lovastatin—ITGAL—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—CD8A—acquired immunodeficiency syndrome	6.82e-05	0.0438	CbGpPWpGaD
Lovastatin—ITGAL—Focal Adhesion—ACTG1—acquired immunodeficiency syndrome	6.76e-05	0.0434	CbGpPWpGaD
Lovastatin—ITGAL—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—HLA-B—acquired immunodeficiency syndrome	6.56e-05	0.0421	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	4.99e-05	0.032	CbGpPWpGaD
Lovastatin—SLCO1A2—Transport of organic anions—ALB—acquired immunodeficiency syndrome	4.54e-05	0.0291	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—APOBEC3G—acquired immunodeficiency syndrome	4.24e-05	0.0272	CbGpPWpGaD
Lovastatin—SLCO1B1—Transport of organic anions—ALB—acquired immunodeficiency syndrome	3.88e-05	0.0249	CbGpPWpGaD
Lovastatin—SLCO1A2—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	3.36e-05	0.0216	CbGpPWpGaD
Lovastatin—SLCO1B1—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	2.87e-05	0.0184	CbGpPWpGaD
Lovastatin—HDAC2—Transcription—CCNT1—acquired immunodeficiency syndrome	2.05e-05	0.0132	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear SMAD2/3 signaling—IL10—acquired immunodeficiency syndrome	1.89e-05	0.0121	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—CSF2—acquired immunodeficiency syndrome	1.85e-05	0.0119	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—IL4—acquired immunodeficiency syndrome	1.82e-05	0.0117	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—IFNA1—acquired immunodeficiency syndrome	1.79e-05	0.0115	CbGpPWpGaD
Lovastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	1.78e-05	0.0114	CbGpPWpGaD
Lovastatin—SLCO1A2—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	1.76e-05	0.0113	CbGpPWpGaD
Lovastatin—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	1.68e-05	0.0108	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—ACTG1—acquired immunodeficiency syndrome	1.62e-05	0.0104	CbGpPWpGaD
Lovastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	1.58e-05	0.0101	CbGpPWpGaD
Lovastatin—HDAC2—Factors involved in megakaryocyte development and platelet production—IFNA1—acquired immunodeficiency syndrome	1.58e-05	0.0101	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.56e-05	0.01	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	1.5e-05	0.00965	CbGpPWpGaD
Lovastatin—SLCO1B1—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	1.5e-05	0.00964	CbGpPWpGaD
Lovastatin—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	1.44e-05	0.00923	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—CSF2—acquired immunodeficiency syndrome	1.4e-05	0.00899	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—MBL2—acquired immunodeficiency syndrome	1.33e-05	0.00854	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of Telomerase—IFNG—acquired immunodeficiency syndrome	1.28e-05	0.00819	CbGpPWpGaD
Lovastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	1.23e-05	0.00789	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	1.23e-05	0.00786	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	1.21e-05	0.00778	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	1.17e-05	0.00748	CbGpPWpGaD
Lovastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	1.15e-05	0.00739	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of Telomerase—IL2—acquired immunodeficiency syndrome	1.13e-05	0.00728	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—IFNG—acquired immunodeficiency syndrome	1.1e-05	0.00705	CbGpPWpGaD
Lovastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	1.09e-05	0.00701	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CCR2—acquired immunodeficiency syndrome	1.04e-05	0.00669	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—IL2—acquired immunodeficiency syndrome	9.77e-06	0.00627	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	9.48e-06	0.00608	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	9.48e-06	0.00608	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	9.41e-06	0.00604	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IFNA1—acquired immunodeficiency syndrome	9.4e-06	0.00603	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—ALB—acquired immunodeficiency syndrome	9.14e-06	0.00586	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CD79A—acquired immunodeficiency syndrome	9.12e-06	0.00585	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	8.21e-06	0.00527	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—TAT—acquired immunodeficiency syndrome	8.17e-06	0.00524	CbGpPWpGaD
Lovastatin—HDAC2—Signaling events mediated by HDAC Class I—TNF—acquired immunodeficiency syndrome	8.07e-06	0.00518	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	8.05e-06	0.00516	CbGpPWpGaD
Lovastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	7.96e-06	0.00511	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CD40LG—acquired immunodeficiency syndrome	7.44e-06	0.00477	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—IL2—acquired immunodeficiency syndrome	7.41e-06	0.00475	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CSF2—acquired immunodeficiency syndrome	7.35e-06	0.00472	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CD8A—acquired immunodeficiency syndrome	7.35e-06	0.00472	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—HLA-B—acquired immunodeficiency syndrome	7.07e-06	0.00454	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	6.96e-06	0.00447	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—AGPS—acquired immunodeficiency syndrome	6.95e-06	0.00446	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—TAT—acquired immunodeficiency syndrome	6.66e-06	0.00427	CbGpPWpGaD
Lovastatin—HDAC2—Disease—APOBEC3G—acquired immunodeficiency syndrome	6.23e-06	0.004	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	6.22e-06	0.00399	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	6.22e-06	0.00399	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	6.13e-06	0.00393	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	6.05e-06	0.00388	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	5.92e-06	0.0038	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—IL6—acquired immunodeficiency syndrome	5.74e-06	0.00368	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—CCNT1—acquired immunodeficiency syndrome	5.71e-06	0.00366	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—AGPS—acquired immunodeficiency syndrome	5.66e-06	0.00363	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—TAT—acquired immunodeficiency syndrome	5.66e-06	0.00363	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—IFNA1—acquired immunodeficiency syndrome	5.51e-06	0.00353	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CCNT1—acquired immunodeficiency syndrome	5.3e-06	0.0034	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—TAT—acquired immunodeficiency syndrome	4.93e-06	0.00316	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—AGPS—acquired immunodeficiency syndrome	4.81e-06	0.00309	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.63e-06	0.00297	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—TAT—acquired immunodeficiency syndrome	4.6e-06	0.00295	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IFNG—acquired immunodeficiency syndrome	4.37e-06	0.0028	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—CSF2—acquired immunodeficiency syndrome	4.31e-06	0.00276	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CD4—acquired immunodeficiency syndrome	4.22e-06	0.00271	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—TAT—acquired immunodeficiency syndrome	4.22e-06	0.0027	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	4.19e-06	0.00269	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.13e-06	0.00265	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—AGPS—acquired immunodeficiency syndrome	3.91e-06	0.00251	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IL2—acquired immunodeficiency syndrome	3.89e-06	0.00249	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—TAT—acquired immunodeficiency syndrome	3.87e-06	0.00248	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.76e-06	0.00241	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.71e-06	0.00238	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3.71e-06	0.00238	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	3.66e-06	0.00235	CbGpPWpGaD
Lovastatin—SLCO1A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	3.61e-06	0.00232	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—AGPS—acquired immunodeficiency syndrome	3.59e-06	0.0023	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.36e-06	0.00215	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—AGPS—acquired immunodeficiency syndrome	3.29e-06	0.00211	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	3.25e-06	0.00209	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.2e-06	0.00205	CbGpPWpGaD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	3.09e-06	0.00198	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—ALB—acquired immunodeficiency syndrome	2.81e-06	0.0018	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.8e-06	0.0018	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—TAT—acquired immunodeficiency syndrome	2.8e-06	0.00179	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CXCR4—acquired immunodeficiency syndrome	2.78e-06	0.00179	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—TAT—acquired immunodeficiency syndrome	2.42e-06	0.00155	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AGPS—acquired immunodeficiency syndrome	2.38e-06	0.00153	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	2.37e-06	0.00152	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.29e-06	0.00147	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IL6—acquired immunodeficiency syndrome	2.28e-06	0.00146	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—IL2—acquired immunodeficiency syndrome	2.28e-06	0.00146	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—TAT—acquired immunodeficiency syndrome	2.16e-06	0.00139	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—IL6—acquired immunodeficiency syndrome	2.11e-06	0.00136	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	2.11e-06	0.00135	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.07e-06	0.00133	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AGPS—acquired immunodeficiency syndrome	2.06e-06	0.00132	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	1.99e-06	0.00128	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	1.97e-06	0.00126	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.95e-06	0.00125	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.95e-06	0.00125	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.93e-06	0.00124	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CCR5—acquired immunodeficiency syndrome	1.91e-06	0.00122	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AGPS—acquired immunodeficiency syndrome	1.84e-06	0.00118	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.84e-06	0.00118	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.79e-06	0.00115	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	1.69e-06	0.00108	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	1.68e-06	0.00108	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.67e-06	0.00107	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.65e-06	0.00106	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.57e-06	0.00101	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.48e-06	0.000952	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.46e-06	0.000937	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—ALB—acquired immunodeficiency syndrome	1.42e-06	0.000914	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.34e-06	0.000857	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.3e-06	0.000834	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CD4—acquired immunodeficiency syndrome	1.2e-06	0.000769	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.17e-06	0.00075	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—ALB—acquired immunodeficiency syndrome	1.16e-06	0.000745	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.11e-06	0.000709	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—ALB—acquired immunodeficiency syndrome	9.87e-07	0.000633	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.49e-07	0.000609	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—ALB—acquired immunodeficiency syndrome	8.6e-07	0.000552	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.47e-07	0.000543	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ALB—acquired immunodeficiency syndrome	8.02e-07	0.000515	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	7.86e-07	0.000504	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.72e-07	0.000495	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.72e-07	0.000495	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ALB—acquired immunodeficiency syndrome	7.35e-07	0.000472	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ALB—acquired immunodeficiency syndrome	6.75e-07	0.000433	CbGpPWpGaD
Lovastatin—HDAC2—Disease—IL6—acquired immunodeficiency syndrome	6.48e-07	0.000416	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	4.88e-07	0.000313	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.54e-07	0.000291	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	4.22e-07	0.000271	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	3.77e-07	0.000242	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	3.68e-07	0.000236	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	3.47e-07	0.000222	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	3.44e-07	0.000221	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.27e-07	0.000145	CbGpPWpGaD
